| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ramaswamy Vivek | 12% | +3.9% | $820,440,003 | +$9.89 | 82,956,522 | +0% | Ramaswamy Vivek | 31 Mar 2025 |
| FMR LLC | 8.2% | $610,046,998 | 55,509,281 | FMR LLC | 30 Jun 2025 | |||
| SB INVESTMENT ADVISERS (UK) LTD | 5.8% | -30% | $609,967,872 | -$328,962,663 | 40,315,127 | -35% | SB Investment Advisers (UK) Limited | 30 Sep 2025 |
| MORGAN STANLEY | 5.5% | $413,736,969 | 37,646,676 | Morgan Stanley | 30 Jun 2025 | |||
| QVT Financial LP | 4.3% | -55% | $351,404,355 | -$435,489,242 | 29,381,635 | -55% | QVT Financial LP | 30 Jun 2025 |
| VIKING GLOBAL INVESTORS LP | 3.4% | -32% | $356,989,793 | -$161,027,803 | 23,594,831 | -31% | VIKING GLOBAL INVESTORS LP | 30 Sep 2025 |
As of 30 Sep 2025, 333 institutional investors reported holding 501,599,603 shares of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV). This represents 72% of the company’s total 695,088,397 outstanding shares.
The largest institutional shareholders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) together control 59% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 8.7% | 60,766,984 | +9.5% | 0.05% | $919,404,470 |
| MORGAN STANLEY | 6.4% | 44,322,857 | -0.83% | 0.04% | $670,604,841 |
| SB INVESTMENT ADVISERS (UK) LTD | 5.8% | 40,315,127 | -33% | 4.6% | $609,967,872 |
| BlackRock, Inc. | 5.7% | 39,724,879 | -1.5% | 0.01% | $601,037,405 |
| VANGUARD GROUP INC | 5.6% | 38,804,928 | -1.3% | 0.01% | $587,118,561 |
| QVT Financial LP | 4.2% | 29,381,635 | 0% | 49% | $444,544,138 |
| VIKING GLOBAL INVESTORS LP | 3.4% | 23,594,831 | -31% | 0.93% | $356,989,793 |
| Rubric Capital Management LP | 2.9% | 20,000,000 | -1.8% | 4.1% | $302,600,000 |
| STATE STREET CORP | 2.7% | 18,700,144 | -5.4% | 0.01% | $282,933,179 |
| Patient Square Capital LP | 1.8% | 12,480,000 | 0% | 51% | $188,822,400 |
| Two Seas Capital LP | 1.7% | 11,754,164 | +11% | 11% | $177,840,501 |
| DIMENSIONAL FUND ADVISORS LP | 1.3% | 9,308,710 | +18% | 0.03% | $140,839,135 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2% | 8,202,594 | +5.8% | 0.01% | $124,128,691 |
| PERCEPTIVE ADVISORS LLC | 1.1% | 7,368,461 | +121% | 3.3% | $111,484,815 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1% | 7,232,383 | +247% | 0.17% | $109,425,955 |
| Bank of New York Mellon Corp | 0.67% | 4,630,948 | +2.8% | 0.01% | $70,066,244 |
| BlackBarn Capital Partners LP | 0.63% | 4,400,000 | -4.9% | 22% | $66,572,000 |
| STEMPOINT CAPITAL LP | 0.6% | 4,197,187 | +597% | 13% | $63,503,439 |
| MARSHALL WACE, LLP | 0.57% | 3,978,001 | +316% | 0.07% | $60,187,155 |
| BAKER BROS. ADVISORS LP | 0.54% | 3,767,773 | 0% | 0.41% | $57,006,405 |
| Whitefort Capital Management, LP | 0.51% | 3,532,000 | -9% | 18% | $53,439,160 |
| ADAR1 Capital Management, LLC | 0.48% | 3,347,501 | +72% | 5.1% | $50,647,690 |
| NORTHERN TRUST CORP | 0.47% | 3,283,061 | +1.5% | 0.01% | $49,672,712 |
| Sofinnova Investments, Inc. | 0.45% | 3,149,270 | +2% | 2.9% | $47,648,455 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.45% | 3,117,731 | +7.9% | 0.01% | $47,171,270 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 10,624,914 | $230,741,915 | +$162,328,299 | $21.70 | 42 |
| 2025 Q3 | 501,599,603 | $7,589,043,254 | -$163,013,521 | $15.13 | 333 |
| 2025 Q2 | 514,772,354 | $5,801,411,223 | -$418,510,063 | $11.27 | 337 |
| 2025 Q1 | 553,328,019 | $5,583,774,451 | -$111,455,380 | $10.09 | 309 |
| 2024 Q4 | 562,437,210 | $6,653,059,125 | -$34,627,484 | $11.83 | 311 |
| 2024 Q3 | 564,717,839 | $6,516,467,949 | +$176,659,948 | $11.54 | 294 |
| 2024 Q2 | 546,004,341 | $5,771,104,788 | +$197,107,216 | $10.57 | 295 |
| 2024 Q1 | 527,262,232 | $5,557,830,830 | -$345,239,824 | $10.54 | 257 |
| 2023 Q4 | 1,669,703 | $18,785,205 | +$5,932,208 | $11.23 | 6 |
| 2023 Q3 | 543,169,581 | $6,343,617,809 | +$504,745,179 | $11.68 | 201 |
| 2023 Q2 | 497,235,534 | $5,011,846,280 | +$398,881,881 | $10.08 | 176 |
| 2023 Q1 | 459,210,235 | $3,388,856,509 | +$347,670,516 | $7.38 | 142 |
| 2022 Q4 | 411,726,861 | $3,289,521,260 | +$287,409,563 | $7.99 | 107 |
| 2022 Q3 | 370,511,797 | $1,192,936,483 | +$30,768,198 | $3.22 | 74 |
| 2022 Q2 | 360,483,054 | $1,467,026,279 | +$45,712,575 | $4.07 | 70 |
| 2022 Q1 | 349,161,099 | $1,724,678,000 | +$48,178,141 | $4.94 | 49 |
| 2021 Q4 | 339,213,133 | $3,416,732,000 | +$3,374,252,821 | $10.08 | 40 |